# Arrowhead Pharmaceuticals, Inc.: Form 8-K/A, filed Mar 18, 2024

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K/A
- Filed: 2024-03-18
- Accepted by EDGAR: Mar 15, 2024, 19:21 ET
- Period: 2024-02-21
- Accession: 0001628280-24-011557
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000162828024011557/arwr-20240221.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000162828024011557/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000162828024011557/arwr-20240221.htm

Filed Mar 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-011557. Last ingested by Listed: Nov 4, 2026, 07:39 ET. No prices; not investment advice.